Skip to content
Regulayer™Human Control for AI
Book a live demo

Regulated industries · GxP

Safety is engineered and proven. Never assumed.

Regulated manufacturing and life sciences run on one principle: the control is designed into the operation, and it produces evidence that it worked. Regulayer™ brings that principle to AI that acts.

Pharma, biotech, medical devices and semiconductor manufacturing: wherever a step must show which named person allowed it.

Runs inside your environment. Your data does not leave it.

A quality control analyst at work in a laboratory

US FDA · warning letter · 2 April 2026

“Any output or recommendations from an AI agent must be reviewed and cleared by an authorized human representative of your firm’s quality unit.”

Where the rule requires review, the named person in the quality unit clears the output. Regulayer™ checks that clearance before release and seals it, with the reviewer’s name and the moment.

Authority and review

When review is required, record the review.

A standing authority says what a person may allow. It does not show that they looked at this output. Where the rule requires review, Regulayer™ needs the reviewer’s decision on that exact output, and checks it before release. The record names the reviewer, the output and the moment.

The FDA letter concerns AI-written CGMP documents and clearance by the firm’s quality unit. Read the warning letter.

The film · AI in a GMP plant

The AI wrote the batch record. Who cleared it?

In April 2026 the FDA issued a warning letter over AI use: a firm used AI agents to write drug specifications, procedures and master production records, and the FDA asked who in the quality unit, by name, cleared each one. Watch the same work run through the Regulayer™ airlock, and watch each rule light up as the record answers it.

Film · Sample plant, sample people · Batch 105

An AI agent drafts the master production record for Batch 105.

Press Play. Every step is a sample; the rules on the right are real.

The AI

Production agent
Issue master production record v4 to the floor

The airlock

Regulayer™ · Mathematical. Outside the AI.
Is a named person in control?
  • Named person in the quality unit
  • Authority current, this moment
  • Signed on these exact words
  • Record sealed first
Waiting

The real world

Maya Chen, QA Lead
Master production record v4 on the floor
Batch 105 released
The record appears here as it is made.

What each rule asks, and the record that answers it

The record · data integrity

Attributable, contemporaneous, original: a named person, made at the time, bound to the exact document.

Records and signatures

The signature is sealed on the signer’s machine, bound to the record by fingerprint, verifiable years later without us.

The quality unit and release

The named reviewer’s clearance, tied to that exact output, checked before release.

AI in GMP

What produced the output, and continuous human oversight: every output signed as it is written, under a person who can stop it.

AI law

One person pulls the authority and every action after that stops. Every decision, allowed or refused, logged on your own infrastructure.

The model may agree. The action still requires current human authority.Regulayer™ supplies the evidence. The quality unit reads the record and decides. Book a live demo

Competitive landscape · For quality and validation

Your quality system already answers these questions. Regulayer™ answers the one the FDA letter asks.

Each control below is already validated in a regulated site. Regulayer™ works beside them, at the moment an AI output would take effect.

Already in your stack
The question it answers
Regulayer™ beside it
Computer system validation (CSV and CSA)
The question it answersWas the system shown fit for use when it was validated?
Regulayer™ beside itChecks every action after validation, while the system runs.
21 CFR Part 11 audit trails
The question it answersWhat changed in a GxP record, and who changed it?
Regulayer™ beside itAlso records what the AI proposed, and who authorized it before it took effect.
eQMS and document approval
The question it answersWas the procedure reviewed and approved?
Regulayer™ beside itChecks each AI action against the approved authority at the moment it runs.
LIMS and MES user permissions
The question it answersMay this user account perform this step?
Regulayer™ beside itA named person behind each AI action, never a service account or a shared login.
Model validation and monitoring
The question it answersIs the model still performing as validated?
Regulayer™ beside itChecks each action against the approved procedure and holds the action past the set point.
Regulayer™
The question it answersDid an authorized person of the quality unit clear this AI output before it took effect?
What it suppliesThe check before effect, and a signed record an inspector can verify without the vendor.

Categories, not vendors. Each layer answers its own question; Regulayer™ works alongside them.

GxP · Annex 11

Where the audit trail breaks.

Your validated systems produce audit trails by design. The AI a scientist used to summarize a deviation report does not. From inside the system, an AI-drafted deviation summary and a hand-written one are the same keystrokes. The record has to be made where the decision was made.

AttributableA named person.Bound to the entry by their own signature, not a shared account or a tool log.
ContemporaneousMade at the time.Recorded at the review, not assembled for an inspection.
OriginalBound to the exact document.By fingerprint, so the declaration cannot be moved onto a different version.
AccurateWhat was actually checked.In the reviewer’s words. Reported, never scored.
EnduringReadable years later.Whoever holds the record can verify it without an account, a vendor or a live service.
On siteNothing leaves the building.The record is sealed on the machine where the work happened. Nothing about the work, the batch or the product is sent to us.

The regulators, in their own words

One asks who cleared it. The other asks what produced it.

US FDA · warning letter · 2 April 2026
“Any output or recommendations from an AI agent must be reviewed and cleared by an authorized human representative of your firm’s quality unit.”

The firm used AI agents to write drug specifications, procedures and master production records. The FDA did not ban the practice. It required review and clearance by an authorised representative of the firm’s quality unit, under 21 CFR 211.22(c).

The record in the Consequence Library
EU GMP Annex 22 · draft · July 2025
Dynamic models, generative AI and large language models should not be used in critical GMP applications.

Non-critical use stays under continuous human oversight, and a qualified person stays responsible. Where a model informs a decision, that may mean review or test of every output. Still a draft; no effective date announced.

Drafted by EMA’s inspectors with PIC/S, alongside a revised Annex 11

A firm can satisfy the first and still sit outside the second. Both land on the same record: who the person was, what they looked at, and whether it can still be shown a year later.

What each rule asks, and the record that answers it

From the rule to the record.

RuleWhat it asksWhat Regulayer™ records
FDA, 21 CFR 211.22(c)An authorised person in the quality unit reviews and clears AI output before use.The named reviewer’s clearance, tied to that exact output, checked before release.
FDA, 21 CFR 211.68(b)Changes to master production and control records, or other records, are made only by authorized personnel.Every change the AI attempts is checked against the named person’s current authority. A change outside it does not run, and the attempt is sealed.
FDA, 21 CFR 211.188(b)(11)The batch record identifies the persons performing, supervising or checking each significant step, and the person checking any step done by automated equipment.Each step the AI takes carries the named person whose authority covered it, sealed with the action.
FDA, 21 CFR 11.10(g)Authority checks, so that only authorized individuals can use the system, sign or alter a record, or perform the operation at hand.A named person’s current authority, checked at the moment the AI acts. Withdraw it, and the same request stops.
FDA, 21 CFR 11.10(e)Secure, computer-generated, time-stamped audit trails of the entries and actions that create, modify or delete records.Every decision, allowed or stopped, sealed and time-stamped as it happens. Change one character, and the check fails.
EU GMP Annex 22, draftWhat produced the output, continuous human oversight, and possibly review of every output.Heartbeat. Prove the AI. At every output.
FDA and EMA, Good AI Practice, principle 6, January 2026Data provenance, processing steps and analytical decisions documented in a traceable and verifiable manner, in line with GxP.A sealed record of each decision, traceable to the person whose authority covered it, and verifiable without us.
ISPE GAMP Guide: Artificial Intelligence, July 2025Industry good practice for AI in GxP computerised systems.Evidence of human authority at each consequential AI action, sealed and ready for the validation file.
21 CFR Part 11 and EU GMP Annex 11Attributable, contemporaneous records, with signatures bound to the record.The Regulayer™ Receipt: sealed on the signer’s machine, bound to the exact document by fingerprint, verifiable years later without us.
EU AI Act, Article 14Effective human oversight, and the ability to intervene or stop the system.One person pulls the authority, and every action after that stops. Off the authority, an action is sent back to correct.
EU AI Act, Articles 12 and 26Automatic logs over the system’s life, kept under the deployer’s control.Every decision, allowed or refused, recorded locally on your own infrastructure. Nothing about the batch or the product is sent to us.

Sources: 21 CFR Part 211 and 21 CFR Part 11; FDA and EMA, Guiding Principles of Good AI Practice in Drug Development, January 2026; ISPE, GAMP Guide: Artificial Intelligence.

Regulayer™ supplies the evidence. The quality unit reads the record and decides.

When automation in the lab went wrong

The records that were missing.

When AI starts to act

Two companies’ AI agents both say release the batch.

A contract manufacturer and a sponsor each run an AI agent. Both agree the batch can go. The Regulayer™ airlock in each company checks that a named person with the authority to release it is still in control. When that authority is withdrawn, the release cannot commit, and both sides hold the same record of why.

The model may agree. The action still requires current human authority.

Where it is put to work

Anywhere an AI action carries consequences.

Life sciences and GxPBatch release, deviations, quality records.AI inside validated work, with the human authority and the evidence built in.
HealthcareThe chart never leaves the estate.HIPAA audit controls over ePHI. The record of what the system did is still provable.
FinancePayments inside the limit a person set.Over it, the money never moves. Pull the authority, and the next payment stops.Financial services
InsuranceA driving record, for AI.Conduct you can price, verifiable by a party adverse to everyone involved.For insurers
SecurityThe airlock in front of every agent action.Outside the model, fail closed, and a record your SOC and auditor can verify.The security door
Robotics and autonomous labsMachines that act in the physical world.The same airlock in front of every consequential action.
Industrial operationsControl designed into the operation.Local, private and on-premises configurations where the deployment allows.

Any change to a sealed record fails verification. Regulayer™ supplies the evidence; the quality unit makes the determination.

Your deployment

See what your customer receives.

An AI-drafted quality record is one starting workflow. Select your scope in the configurator.

The control

The engine checks the named reviewer’s clearance before the batch releases.

The Transponder™

The quality team sees who cleared it, under what authority, and what happened.

The evidence

An inspector receives the records you choose, with what they cover stated.

Start a pilot

One workflow. Human control, proven on your own systems.

Pick one place in your quality system where an AI action carries consequences: a batch release, a deviation, a method change, a master record. Regulayer™ runs inside your environment, checks each action against the named person’s current authority and any review the rule requires, and seals a record your inspector, auditor or qualified person can check without us.

Withdraw an authority mid-run and the next request stops. Every decision, allowed or stopped, is sealed as it happened. The pilot is paid, and the fee is credited back in the first quarter after the licence is signed.